ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 5536 - 5550 of 5996 products
ASLAN Pharma In-Licenses Rheumatoid Arthritis Treatment from Almirall
$5.00
Available
Ventac Partners In-licenses Diabetes Treatments from Guangzhou Institute
$5.00
Available
China National Biotech to Raise $1.6 Billion in Hong Kong IPO
$5.00
Available
J&J in the Hunt for China Pharma Acquisitions
$5.00
Available
Baxter Gains SFDA Approval for Recombinant Hemophilia Treatment
$5.00
Available
Novozymes Opens Hyaluronic Acid Plant in Tianjin
$5.00
Available
BMS Ups Investment in China R&D and Manufacturing
$5.00
Available
Hisun Pharma to Supply Celsion
$5.00
Available
IPO of Ningbo David Medical Device Greeted Warmly
$5.00
Available
New China-Australia Research Center to Study TCM
$5.00
Available
Conba Pharma Plans $148 Million Private Placement
$5.00
Available
Mindray Acquires Controlling Stake in Optcla Medical Instrument
$5.00
Available
Shanghai Generon Initiates a Phase II Trial for Breast Cancer in the US
$5.00
Available
Enzon and Hisun Announce Strategic Alliance for PEGylation Technology in China
$5.00
Available
Zhejiang Huahai and Breckenridge Sign Agreement for Generic HIV Drug
$5.00
Available